BioCentury | Aug 15, 2018
Emerging Company Profile

Breaking bad biofilms

...a Phase II CF trial of inhaled heparin by early 2019. Zaluvida Corp. AG unit Neem Biotech Ltd.’s...
Items per page:
1 - 1 of 1
BioCentury | Aug 15, 2018
Emerging Company Profile

Breaking bad biofilms

...a Phase II CF trial of inhaled heparin by early 2019. Zaluvida Corp. AG unit Neem Biotech Ltd.’s...
Items per page:
1 - 1 of 1